The five ways research consortia fall apart — and how to prevent them
Governance collapse, IP disputes, unequal workload, communication breakdown, and misaligned milestones. Each failure mode mapped to a structural fix.
Rainpax Global · Research Partnership Series · 12 min read
Research consortia are, by design, optimistic structures. Multiple institutions commit resources and expertise toward a shared scientific objective, pooling capabilities that no single organization could marshal alone. Funders love them. Grant panels reward them. And yet, a significant proportion collapse or underdeliver — not because the science was wrong, but because the structure was.
The problems that bring down research consortia rarely arrive as sudden crises. They accumulate slowly: a decision that nobody makes, an assumption that everybody holds, a workstream that quietly stalls. By the time the consortium reaches a breaking point, the damage has usually been years in the making.
Below are the five structural failure modes we see most consistently — and the mechanisms that actually prevent them.
Governance collapse — when
no one is actually in charge
Most consortium agreements establish a governance structure on paper. Steering committees are named, voting rights allocated, a lead institution designated. What they rarely establish is how decisions actually get made when partners disagree — and in a multi-institution research programme, disagreements are not edge cases. They are the normal operating condition.
Governance collapse typically does not look like conflict. It looks like drift. Decisions are deferred to the next meeting, then the next. Contested questions are tabled indefinitely. The steering committee convenes quarterly but lacks the authority, or the will, to resolve anything substantive. Meanwhile, individual partners begin making unilateral choices about scope, methodology, and resource allocation — because someone has to.
By the time governance failure becomes visible to funders, it has usually restructured the project in ways that are difficult to reverse. Work packages overlap or fall through gaps. Partners have stopped sharing results across institutional boundaries. The consortium operates as a collection of parallel solo projects rather than a coordinated programme.
Warning signs
- Steering committee meetings are consistently postponed or poorly attended
- Action items from previous meetings remain unresolved at subsequent ones
- Individual PIs begin reporting informally that they are "just getting on with it"
- The lead institution begins absorbing decisions that were meant to be collective
- Partners refer to the consortium agreement rarely, if at all
The fix: decision rights, not just decision bodies. A governance structure needs to specify not only who meets, but who decides — and on what. The most robust consortium agreements distinguish between decisions that require full steering committee consensus, decisions that fall within the lead institution's delegated authority, and decisions that sit with individual work-package leads. They also establish a clear escalation path with defined timescales, so that unresolved disputes cannot remain in limbo indefinitely.
Complement this with a mandatory governance review at the midpoint of the project — before a funder review, not in response to one. A mid-term governance audit that examines actual decision-making patterns, not just the structure as written, frequently surfaces problems while they are still correctable.
IP disputes — the rights
nobody agreed on
Intellectual property is the issue most likely to be deferred until it becomes urgent — at which point deferral is no longer an option. In the early stages of a consortium, partners are motivated to agree on the science and get funded. IP discussions feel premature, complicated, and potentially adversarial. So they are postponed.
The postponement tends to hold until something valuable emerges — a novel compound, a clinical dataset, a patentable method. At that point, each institution's legal and technology-transfer offices become involved for the first time, applying institutional policies that were never reconciled against each other and may be fundamentally incompatible. Universities with strong commercialisation mandates will have different default positions from research hospitals, government agencies, or industry partners. What begins as a collaborative research project becomes a multi-party negotiation over assets that already exist.
Disputes of this kind are rarely resolved quickly. They consume senior management time, generate legal costs, and introduce exactly the kind of institutional friction that collaborative research cannot survive. Projects have stalled for years in IP disputes while the science waited.
Warning signs
- The consortium agreement does not specify IP ownership for outputs generated jointly
- Each institution's technology-transfer office has not reviewed and signed the agreement
- Background IP brought into the project is undocumented or not formally licensed in
- Industry partners have different commercialisation expectations than academic partners
- There is no agreed process for deciding when and whether to file patent applications
The fix: negotiate IP before results exist. IP frameworks are far easier to agree when no one knows yet what will be valuable. Establish at the outset: how will foreground IP be owned and licensed? What background IP is each partner contributing, and on what terms? How will revenue from commercialisation be shared?
Insist that all partner institutions' technology-transfer or legal teams are signatories to the consortium agreement — not just research offices. If an institution's legal team has not reviewed the IP provisions, the provisions are effectively unenforceable within that institution. Build in a process for handling unexpected discoveries: a defined decision-making sequence for evaluating, filing, and commercialising IP that partners have agreed to before any discovery is made.
Unequal workload — the contribution gap
that corrodes trust
Consortia are assembled on the basis of what each partner proposes to contribute. By the time the project is underway, those contributions rarely align with what was originally planned. Staff leave. Competing priorities emerge. A partner that was well-resourced at proposal stage has reorganised by implementation. The gap between committed and actual contribution opens — and because consortia operate on trust and goodwill, it typically goes unaddressed until it has become significant.
The partners who are contributing more are acutely aware of it. The partners contributing less are often aware of it too, but in the absence of a formal mechanism for raising the issue, there is no path to resolution that does not feel confrontational. So the imbalance persists, accumulating resentment that eventually manifests as disengagement, withdrawal from shared activities, or open conflict at a moment of crisis.
Unequal contribution also distorts the record of the project. Funder reports reflect the planned division of work, not the actual one. Partners who carried disproportionate load receive proportionate credit. The institutional inequities that produced the imbalance — differences in resources, capacity, and competing demands — are never made visible.
Warning signs
- One or two partners are consistently producing the majority of shared deliverables
- Certain work packages report regularly; others are persistently silent
- Partners reference each other's contributions in informal conversation with unusual specificity
- Staff turnover at one partner has not triggered a formal review of that partner's capacity
- The lead institution has quietly absorbed tasks that sit outside its work package
The fix: visible contribution tracking with structured check-ins. Build a lightweight contribution-tracking mechanism into the project's standard reporting. This does not need to be onerous — a quarterly summary of what each partner has delivered against commitment is sufficient. The goal is not surveillance but visibility: making contribution patterns legible to all partners creates the conditions for addressing imbalances before they calcify.
Pair this with an explicit, low-stakes mechanism for partners to flag capacity issues early — a standing agenda item at steering meetings, or a designated point of contact for confidential early warning. The aim is to normalise the conversation about resource constraints before they become a source of shame or blame. Where genuine imbalances cannot be corrected, they should be formally renegotiated and reflected in the project record.
Communication breakdown — when
silence becomes structural
Research consortia begin with energy. Kick-off meetings are productive. Partners share early results. There is a genuine sense of collaborative momentum. The communication infrastructure — shared repositories, mailing lists, regular calls — is established with good intentions.
Over time, the infrastructure remains in place while the actual communication stops flowing through it. Researchers deposit outputs in shared repositories that nobody reads. Mailing lists become vehicles for announcements rather than dialogue. Regular calls are attended by project managers and administrators, while the scientists whose work is the subject of those calls are not in the room. Bilateral communication between individual researchers — which is often where the real scientific exchange happens — is invisible to the consortium as a whole.
The consequences are serious. Partners make decisions without knowledge of what others are doing. Methodological choices that should have been coordinated diverge. Duplication goes undetected. Opportunities for genuine cross-institutional collaboration are missed because no one knew the opportunity existed. By the time the consortium produces its joint outputs, the scientific work has proceeded in parallel silos for years.
Warning signs
- Shared repositories are updated infrequently and not actively reviewed by partners
- Regular calls have declining attendance and increasingly brief agendas
- Partners discover each other's work through publications rather than internal channels
- There is no shared record of key methodological decisions and their rationale
- Junior researchers across partners do not know their counterparts at other institutions
The fix: design for communication, not just reporting. There is a critical distinction between reporting — which is one-directional and retrospective — and communication, which is dialogic and prospective. Most consortia build reporting infrastructure. Few deliberately build communication infrastructure.
Practical measures include: dedicated working groups at the scientific level (not management level) for each cross-cutting theme; an annual in-person residential where early-career researchers across institutions work together intensively; a structured process for flagging methodological decisions to all partners before they are finalised; and a shared decision log that records not just what was decided, but why. The goal is to make the consortium's collective knowledge accessible to all partners in real time, not retrospectively through reports.
Misaligned milestones — when each partner
is measuring something different
Consortium milestones are typically set at proposal stage, when partners have agreed on a shared research narrative and are collectively optimistic about timelines. By the time the project is underway, the milestones remain — but what each partner means by them may have diverged considerably.
This is partly a language problem. Research milestones are necessarily written at a level of abstraction that allows partners with different methodologies and institutional contexts to claim ownership of them. "Completion of Phase 2 data collection" can mean quite different things to a clinical research centre, a computational modelling group, and a social science team. Each partner proceeds on the basis of its own interpretation, which is entirely consistent with the milestone as written, until the moment those interpretations need to be integrated — at which point the incompatibilities become apparent.
Milestone misalignment is also a timeline problem. Research rarely proceeds at the pace projected in grant applications. When individual partners' timelines slip, the effect on dependent workstreams is rarely tracked systematically. A delay in one work package may make a subsequent milestone unreachable — but because each partner is reporting against its own milestones rather than the consortium's critical path, the cumulative impact is invisible until it is too late to address.
Warning signs
- Milestone definitions in the consortium agreement are high-level and interpretively flexible
- Partners report milestones as achieved without cross-consortium validation
- There is no shared critical-path diagram mapping dependencies between work packages
- Timeline slippages are reported to funders but not flagged internally to dependent partners
- Integration points — where outputs from multiple work packages must converge — are not explicitly planned
The fix: operationalise milestones and map dependencies explicitly. Every consortium milestone should have an agreed operational definition: a specific, concrete description of what "done" means that has been validated by all partners whose work contributes to it. This is more work than writing a grant application milestone — and it is the work that most consortia skip.
Alongside operational definitions, build a dependency map at the outset: which work packages depend on outputs from which other work packages, and by when? Treat this as a living document reviewed at each steering meeting. When a partner's timeline slips, the first question should be: which other partners are affected, and have they been notified? Build an explicit integration timeline — points at which cross-partner outputs must converge — and treat these as hard constraints, not aspirational targets. The integration points are where the value of consortium research is created; they deserve the most careful planning.
The pattern behind the patterns
What unites these five failure modes is that none of them are unforeseeable. Governance ambiguity, IP uncertainty, workload imbalance, communication atrophy, and milestone divergence are predictable features of multi-institution research collaboration — not accidents. They are the structural properties of consortia that have not been deliberately designed against.
The preventive measures described above share a common logic: make implicit assumptions explicit, create mechanisms for early warning rather than crisis response, and build accountability structures that treat problems as correctable rather than as failures. Consortia that manage these challenges well do not avoid problems — they surface and address them while the project still has the capacity to adapt.
At Rainpax Global, we work with research teams and institutions at each stage of the consortium lifecycle — from governance design at proposal stage to programme management through the project period. If you are structuring a new consortium or navigating challenges in an existing one, we would be glad to speak with you.
Get in touch with our team